Targeted Intraparenchymal Delivery of Human NGF by Gene Transfer to the Primate Basal Forebrain for 3 Months Does Not Accelerate β-Amyloid Plaque Deposition
- 1 December 1998
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 154 (2) , 573-582
- https://doi.org/10.1006/exnr.1998.6956
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Stable Complexes Involving Acetylcholinesterase and Amyloid-β Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer’s FibrilsJournal of Neuroscience, 1998
- Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils 1 1Edited by A. R. FershtJournal of Molecular Biology, 1997
- Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s DiseaseJournal of Neuroscience, 1996
- Nerve Growth Factor and Ras Regulate β‐Amyloid Precursor Protein Gene Expression in PC12 CellsJournal of Neurochemistry, 1996
- Nerve growth factor does not influence the expression of β amyloid precursor protein mRNA in rat brain: in vivo and in vitro studiesBrain Research, 1993
- A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's DiseaseNew England Journal of Medicine, 1992
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992
- Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factorNature, 1987
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982